Form 144 - Report of proposed sale of securities:
SEC Accession No. 0001959173-25-000304
Filing Date
2025-01-15
Accepted
2025-01-15 09:59:40
Documents
1

Document Format Files

Seq Description Document Type Size
1 primary_doc.html 144  
1 primary_doc.xml 144 2958
  Complete submission text file 0001959173-25-000304.txt   4466
Mailing Address 343 COMMERCIAL STREET #314 BOSTON MA 02109
Business Address
Thrall James H (Reporting) CIK: 0001315048 (see all company filings)

Type: 144

Mailing Address 331 TREBLE COVE ROAD NORTH BILLERICA MA 01862
Business Address 331 TREBLE COVE ROAD NORTH BILLERICA MA 01862 978 671-8001
Lantheus Holdings, Inc. (Subject) CIK: 0001521036 (see all company filings)

EIN.: 352318913 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 144 | Act: 33 | File No.: 001-36569 | Film No.: 25531417
SIC: 2835 In Vitro & In Vivo Diagnostic Substances
(CF Office: 03 Life Sciences)